Avalo Therapeutics Inc (AVTX)

Apr 16, 2025

Avalo Therapeutics (AVTX) Sees New Options Listings for April | - GuruFocus

Apr 16, 2025

Apr 16, 2025

Avalo Therapeutics (AVTX) Sees New Options Listings for April | AVTX Stock News - GuruFocus

Apr 16, 2025

Apr 16, 2025

Seven new option listings and one option delisting on April 16th - TipRanks

Apr 16, 2025

Apr 15, 2025

Avalo Therapeutics Reports 2024 Financial Results - TipRanks

Apr 15, 2025

Apr 04, 2025

(AVTX) On The My Stocks Page - news.stocktradersdaily.com

Apr 04, 2025

Apr 04, 2025

AVTX stock touches 52-week low at $5.98 amid market challenges - Investing.com Australia

Apr 04, 2025

Apr 04, 2025

AVTX stock touches 52-week low at $5.98 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025

Mar 29, 2025

Avalo Therapeutics (NASDAQ:AVTX) Coverage Initiated at Stifel Nicolaus - MarketBeat

Mar 29, 2025

Mar 28, 2025

Avalo Therapeutics (AVTX) to Release Earnings on Friday - Defense World

Mar 28, 2025

Mar 28, 2025

Analysts Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) Target Price at $33.00 - Defense World

Mar 28, 2025

Mar 26, 2025

Avalo Therapeutics names new Chairman amid growth phase By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Avalo Therapeutics Names Michael Heffernan as Board Chairman - MarketScreener

Mar 26, 2025

Mar 26, 2025

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board - GlobeNewswire

Mar 26, 2025

Mar 26, 2025

Avalo Therapeutics Appoints Michael Heffernan As Chairman Of The Board - MarketScreener

Mar 26, 2025

Mar 26, 2025

Avalo Therapeutics names new Chairman amid growth phase - Investing.com

Mar 26, 2025

Mar 26, 2025

DynaCERT And Avalo Therapeutics Poised For Growth - Evrim Ağacı

Mar 26, 2025

Mar 26, 2025

Avalo Therapeutics (NASDAQ:AVTX) Now Covered by Analysts at Stifel Nicolaus - Defense World

Mar 26, 2025

Mar 25, 2025

Stifel initiates Avalo Therapeutics stock with a Buy rating By Investing.com - Investing.com Australia

Mar 25, 2025

Mar 25, 2025

Jefferies Initiates Coverage of Avalo Therapeutics (AVTX) with Buy Recommendation - Nasdaq

Mar 25, 2025

Mar 25, 2025

Avalo Therapeutics 'Represents An Attractive Pure-Play,' Analyst Initiates Coverage With Over 300% Stock Upside - Benzinga

Mar 25, 2025

Mar 25, 2025

Jefferies starts Avalo stock with Buy, sets $23 price target By Investing.com - Investing.com Australia

Mar 25, 2025

Mar 25, 2025

This Clearway Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

Mar 25, 2025

Mar 25, 2025

Stifel Initiates Coverage of Avalo Therapeutics (AVTX) with Buy Recommendation - Nasdaq

Mar 25, 2025

Mar 25, 2025

Stifel Initiates Avalo Therapeutics at Buy With $36 Price Target - MarketScreener

Mar 25, 2025

Mar 25, 2025

How the (AVTX) price action is used to our Advantage - news.stocktradersdaily.com

Mar 25, 2025

Mar 25, 2025

Jefferies starts Avalo stock with Buy, sets $23 price target - Investing.com

Mar 25, 2025

Mar 24, 2025

Stifel initiates Avalo Therapeutics stock with a Buy rating - Investing.com India

Mar 24, 2025

Mar 24, 2025

Oppenheimer maintains Avalo stock Outperform with $35 target By Investing.com - Investing.com Canada

Mar 24, 2025

Mar 24, 2025

Oppenheimer maintains Avalo stock Outperform with $35 target - Investing.com

Mar 24, 2025

Mar 24, 2025

Equities Analysts Set Expectations for AVTX Q1 Earnings - Defense World

Mar 24, 2025

Mar 24, 2025

Wedbush Research Analysts Lift Earnings Estimates for AVTX - Defense World

Mar 24, 2025

Mar 23, 2025

Wedbush Forecasts Increased Earnings for Avalo Therapeutics - The AM Reporter

Mar 23, 2025

Mar 22, 2025

HC Wainwright Reiterates Neutral Rating for Avalo Therapeutics (NASDAQ:AVTX) - Defense World

Mar 22, 2025

Mar 22, 2025

Q1 EPS Estimates for Avalo Therapeutics Boosted by Wedbush - Defense World

Mar 22, 2025

Mar 20, 2025

Avalo Reports 2024 Financial Results and Recent Business Updates - GlobeNewswire

Mar 20, 2025

Mar 20, 2025

Avalo Therapeutics Reports Business Updates and Financial Results for 2024, Highlights Phase 2 LOTUS Trial Progress for AVTX-009 in Hidradenitis Suppurativa - Nasdaq

Mar 20, 2025

Mar 20, 2025

Avalo Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 20, 2025

Mar 20, 2025

Avalo Therapeutics (AVTX) Expected to Announce Quarterly Earnings on Thursday - Defense World

Mar 20, 2025

Mar 12, 2025

AVTX’s 52-Week Rollercoaster: From $4.35 to $34.46 – What’s Next for Investors? - The InvestChronicle

Mar 12, 2025

Mar 07, 2025

PSTV Rallies, TOVX Gears Up For VIRAGE Trial Data, Will AVTX's LOTUS Bloom? - RTTNews

Mar 07, 2025

Mar 04, 2025

(AVTX) Investment Analysis - Stock Traders Daily

Mar 04, 2025

Mar 03, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Update - Defense World

Mar 03, 2025

Mar 02, 2025

Avalo Therapeutics (NASDAQ:AVTX) Coverage Initiated at Piper Sandler - Defense World

Mar 02, 2025

Mar 01, 2025

Avalo Therapeutics (NASDAQ:AVTX) Coverage Initiated by Analysts at Piper Sandler - MarketBeat

Mar 01, 2025

Feb 28, 2025

Piper Sandler Initiates Coverage of Avalo Therapeutics (AVTX) with Overweight Recommendation - Nasdaq

Feb 28, 2025

Feb 28, 2025

This CoStar Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga India

Feb 28, 2025

Feb 28, 2025

Piper Sandler Initiates Avalo Therapeutics at Overweight With $48 Price Target -February 28, 2025 at 07:54 am EST - Marketscreener.com

Feb 28, 2025

Feb 28, 2025

Piper Sandler sets $48 target on Avalo Therapeutics stock - Investing.com

Feb 28, 2025

Feb 27, 2025

Avalo Therapeutics (NASDAQ:AVTX) Upgraded by Wedbush to "Strong-Buy" Rating - MarketBeat

Feb 27, 2025

Feb 25, 2025

Avalo Therapeutics (NASDAQ:AVTX) Now Covered by Analysts at Wedbush - MarketBeat

Feb 25, 2025

Feb 24, 2025

Avalo Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Feb 24, 2025

Feb 23, 2025

Avalo Therapeutics initiated with an Outperform at Wedbush - MSN

Feb 23, 2025